Another critical question that remains to be answered regarding the BLS in AD is whether the manipulation of brain lymphatic drainage could modify levels of AGES-activated microglia, phosphorylated tau protein, activated T lymphocytes, pro-inflammatory cytokines, toxic metals, and oxidized lipoproteins (ox-LDL). Here, MAPT is linked to Alzheimer disease.